Prolor Biotech (PBTH +11.1%) follows up last week's strong gains with a double-digit move up....

|By:, SA News Editor

Prolor Biotech (PBTH +11.1%) follows up last week's strong gains with a double-digit move up. M.E. Garza attributes the buying to M&A chatter emerging out of a major healthcare conference last week in San Francisco on the strength of the firm's promising drug pipeline.